Testing effectiveness (Phase 2)Study completedNCT03455491
What this trial is testing
Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections
Who this might be right for
Acute Respiratory Viral InfectionsInfluenza
PHARMENTERPRISES LLC 120